Skip to main content
EVLV $5.80 +0.69%
EVLV logo

EVLV · Evolv Technologies Holdings, Inc.

Track EVLV — free
$5.80 +0.04 (+0.69%) At close · Aug 14
Market Cap
$1.05B
Shares
181.13M
All earnings calls

Earnings call · FY2023 Q4

Evolv Technologies Holdings, Inc. Q4 FY2023 Earnings Call

Evolv Technologies Holdings, Inc. Q4 FY2023 Earnings Call

Concluded Feb 29, 2024
Feb 29, 2024 47 turns
Period
FY2023 Q4
Runtime
Sources
3 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Revenue growth and ARR expansion 55 Regulatory and legal matters (FTC/SEC) 53 Weapons detection and visitor screening volume 37 Path to profitability and margin expansion 26 Vertical end markets (education, healthcare, workplace) 20 Channel partners and go-to-market 18

Management tone

Confident

Net tone +72 · low hedging

Grounding quotes
  • “We're delighted to report revenue of $80.4 million in 2023, up 46% year-over-year.”
  • “we're really happy with our strong results in Q4. We had record revenue, record ARR, and our record RPO.”
  • “We remain optimistic about reaching an EBITDA neutral state by the second quarter of 2025.”
  • “we see a well-lit path to positive adjusted EBITDA with no additional capital this year.”

Forward guidance

10 guided metrics

Management's latest ranges and targets are included below.

Research coverage

3 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $20.58M -1.5% YoY
Gross margin 46.5% +46.2 pp YoY
Net income -$17.20M

Research materials

Open the source you need; every reader stays inside this workspace.

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided Actual
Full year revenues
2024
$115M $103.87M below
ARR
exit 2024
$108M – $112M
Adjusted gross margins
2024
60%
Sales and marketing spend as a percentage of revenue
longer term
25% – 30%
Cash and marketable securities Initiated
when we reach positive adjusted EBITDA in the first half of 2025
at least $75M
Adjusted gross margin
2024
60%
R&D spend rate
as early as 2025
15% – 20%
Sales and marketing spend
longer term
25% – 30%
G&A spending level
over the next few years
10% – 12%
Adjusted EBITDA margins
longer term
10% – 15%

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Subscription And Circulation$12.47M
Service$4.86M
Product$1.85M
License Fee and Other Revenue$1.41M
Full-screen source Call document